InvestorsHub Logo
Followers 42
Posts 3562
Boards Moderated 0
Alias Born 07/29/2006

Re: 123414 post# 3381

Tuesday, 08/28/2018 7:39:09 PM

Tuesday, August 28, 2018 7:39:09 PM

Post# of 4159
10m bucks gets them to interim results where there is $20m in warrants plus the warrants from this raise...

the special PP private interest want to see efficacy at 50 patients lets say if the trial goes in 2 cohorts.

Also those guys didn't want warrants under their own holdings.. so .50 is a minimum now..

the most significant data is 6 months in predicting 12.. and is the retreatment interval for Phase 2.

Therefore 'maximum' confidence can be ascertained at an 'intermediate-endpoints'

which is what Dr.Gottlieb speaks about when discussing small companies with trials with outsized results that are over and above expectations regardign 'Cures Act'

The same NIH institution that funded Dr.McFarland 3.2/5 years Dr.Collins is Director who presents with Dr.Gottlieb.. so we forsure have attention cross border in top medical spots.

This trial is designed for out maximum-success potential.. IMO after watching the AGM

The path seems clear to me with this logic. (but hey) i didn't make money with pot or crypto so IMHO...



Hopefully we can get a nice 2018 run


GRO3 INFORMATION

Love stocks that have; Revenues, No Toxic Debts & Innovative
project ambitions.